银河证券每日晨报-20250509

Macro Overview - The Federal Reserve is expected to maintain interest rates for a longer period, with a higher probability of rate cuts occurring in the second half of the year, although the likelihood of a July cut is decreasing due to slow tariff negotiations and resilient economic growth [1][2][7] - The A-share market is anticipated to show stronger resilience due to ongoing policy support aimed at stabilizing and activating the capital market, with a focus on mergers and acquisitions for company transformation [1][12] Equity Market Insights - The U.S. stock market is facing multiple pressures that could trigger a downward spiral, despite some recovery due to eased tariff policies and fiscal stimulus expectations [1][17] - The A-share market is expected to benefit from policies promoting long-term capital inflows and corporate restructuring, with a focus on high-margin assets and sectors boosted by policy support [1][17] Fixed Income Strategy - The convertible bond market is experiencing a decline, with a focus on identifying undervalued securities and opportunities related to redemption clauses [19][20] - The performance of convertible bonds is closely tied to the overall equity market, with a recommendation for a diversified portfolio including specific convertible bonds [19][21] Non-Banking Financial Sector - The "Action Plan for Promoting the High-Quality Development of Public Funds" aims to enhance investor returns and expand the scale of equity investments in public funds, which is crucial for long-term capital market stability [24][28] - The plan emphasizes performance-based fee structures and long-term investment strategies to improve the overall quality of the public fund industry [25][26] Automotive Industry - The automotive sector has shown strong performance in Q1 2025, with significant fund allocation and a continuous increase in holdings by public funds, driven by favorable policies and market conditions [30][31] - The sector is expected to maintain high growth momentum due to new product launches and consumer demand stimulation [30][31] Pharmaceutical Sector - The pharmaceutical industry is under pressure due to cost control measures, with a notable decline in revenue and profit margins, but there are signs of recovery in the innovative drug segment [36][39] - The innovative drug sector is projected to benefit from supportive policies and improving market conditions, leading to potential value recovery [38][39]